XENE
Xenon Pharmaceuticals·NASDAQ
--
--(--)
--
--(--)
XENE fundamentals
Xenon Pharmaceuticals (XENE) released its earnings on Nov 3, 2025: revenue was 0 (YoY 0.00%), beat estimates; EPS was -1.15 (YoY -41.98%), beat estimates.
Revenue / YoY
0
0.00%
EPS / YoY
-1.15
-41.98%
Report date
Nov 3, 2025
XENE Earnings Call Summary for Q3,2025
- Phase III Milestone: 380 patients randomized in X-TOLE2, targeting 2026 readout for azetukalner in focal onset seizures.
- Therapeutic Expansion: Azetukalner in MDD and BPD trials (X-NOVA2, X-CEED) with Phase I pain programs advancing.
- Financial Strength: $555M cash, sufficient for operations into 2027; new CFO driving commercial readiness for 2027 launch.
- Differentiation: AZK's QD dosing, no titration, and mood benefits position it for 30-40% U.S. epilepsy market share.
EPS
Revenue
Revenue & Expenses
Key Indicators
Xenon Pharmaceuticals (XENE) key financial stats and ratios, covering profitability, financial health, and leverage.
Xenon Pharmaceuticals (XENE)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.
Trend
Breakdown
Xenon Pharmaceuticals (XENE)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.
Trend
Breakdown
Xenon Pharmaceuticals (XENE)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.
Trend
Breakdown
Where does Xenon Pharmaceuticals (XENE) generate its revenue? Explore its key revenue streams and top earning regions.
By Business
Data source:
By Region
Data source:
Track Xenon Pharmaceuticals (XENE) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History
Payout Ratio
Dividend Yield
You can ask Aime
What is the revenue and EPS growth rate for Xenon Pharmaceuticals year over year?What factors drove the changes in Xenon Pharmaceuticals's revenue and profit?What were the key takeaways from Xenon Pharmaceuticals’s earnings call?What guidance did Xenon Pharmaceuticals's management provide for the next earnings period?What is the market's earnings forecast for Xenon Pharmaceuticals next quarter?What does Xenon Pharmaceuticals do and what are its main business segments?What is Xenon Pharmaceuticals's gross profit margin?Did Xenon Pharmaceuticals beat or miss consensus estimates last quarter?
